Perrigo Company (NYSE:PRGO) to Release Quarterly Earnings on Thursday
Perrigo Company (NYSE:PRGO) will announce its earnings results before the market opens on Thursday, August 10th. Analysts expect the company to announce earnings of $0.94 per share for the quarter. Perrigo has set its FY17 guidance at $4.15-4.50 EPS.
Perrigo (NYSE:PRGO) last announced its quarterly earnings data on Tuesday, May 30th. The company reported $1.05 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.99 by $0.06. Perrigo had a negative net margin of 43.81% and a positive return on equity of 11.79%. The firm had revenue of $1.19 billion during the quarter, compared to analysts’ expectations of $1.19 billion. During the same quarter last year, the business earned $1.32 earnings per share. The business’s revenue for the quarter was down 11.4% compared to the same quarter last year. On average, analysts expect Perrigo to post $4.27 EPS for the current fiscal year and $5.02 EPS for the next fiscal year.
Shares of Perrigo Company (PRGO) opened at 67.51 on Tuesday. The company has a 50 day moving average of $74.16 and a 200 day moving average of $73.30. Perrigo Company has a 52 week low of $65.47 and a 52 week high of $99.14. The firm’s market cap is $9.68 billion.
PRGO has been the subject of a number of recent analyst reports. Deutsche Bank AG decreased their target price on shares of Perrigo from $87.00 to $86.00 and set a “buy” rating for the company in a research report on Wednesday, April 19th. Canaccord Genuity set a $86.00 target price on shares of Perrigo and gave the company a “buy” rating in a research report on Monday, May 22nd. Cantor Fitzgerald set a $85.00 target price on shares of Perrigo and gave the company a “buy” rating in a research report on Monday, July 24th. ValuEngine lowered shares of Perrigo from a “buy” rating to a “hold” rating in a research report on Friday, June 2nd. Finally, Royal Bank Of Canada reiterated a “hold” rating and issued a $66.00 target price on shares of Perrigo in a research report on Wednesday, May 24th. Three investment analysts have rated the stock with a sell rating, nine have assigned a hold rating and seven have issued a buy rating to the company’s stock. The company presently has an average rating of “Hold” and a consensus target price of $84.97.
Perrigo Company Profile
Perrigo Company plc is a global healthcare supplier that develops, manufactures and distributes over-the-counter (OTC) and generic prescription (Rx) pharmaceuticals, infant formulas, nutritional products, animal health, dietary supplements, active pharmaceutical ingredients (API), and medical diagnostic products, and Multiple Sclerosis drug Tysabri.
Receive News & Ratings for Perrigo Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Perrigo Company and related companies with MarketBeat.com's FREE daily email newsletter.